wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41059063-55E033F9-18E6-4A8C-863E-D78742226AC4
Q41059063-55E033F9-18E6-4A8C-863E-D78742226AC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41059063-55E033F9-18E6-4A8C-863E-D78742226AC4
Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results.
P2860
Q41059063-55E033F9-18E6-4A8C-863E-D78742226AC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41059063-55E033F9-18E6-4A8C-863E-D78742226AC4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39bc11f446d0baddfaf0821da4f0ea03fe9a92a5
P2860
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine.